Toyoda K, Yoshimura S, Nakai M, Koga M, Sasahara Y, Sonoda K, Kamiyama K, Yazawa Y, Kawada S, Sasaki M, Terasaki T, Miwa K, Koge J, Ishigami A, Wada S, Iwanaga Y, Miyamoto Y, Minematsu K, Kobayashi S, Iihara K, Itabashi R, Kitazono T, Ogasawara K, Nogawa S, Uno M, Ikawa F, Yamaguchi S, Ito A (2022) Twenty-year change in severity and outcome of ischemic and hemorrhagic strokes. JAMA Neurol 79:61
Sexton E, McLoughlin A, Williams DJ, Merriman NA, Donnelly N, Rohde D, Hickey A, Wren MA, Bennett K (2019) Systematic review and meta-analysis of the prevalence of cognitive impairment no dementia in the first year post-stroke. Eur Stroke J 4:160–171
Article PubMed PubMed Central Google Scholar
Rost NS, Brodtmann A, Pase MP, van Veluw SJ, Biffi A, Duering M, Hinman JD, Dichgans M (2022) Post-stroke cognitive impairment and dementia. Circ Res 130:1252–1271
Article CAS PubMed Google Scholar
Lo JW, Crawford JD, Desmond DW, Godefroy O, Jokinen H, Mahinrad S, Bae HJ, Lim JS, Kohler S, Douven E, Staals J, Chen C, Xu X, Chong EJ, Akinyemi RO, Kalaria RN, Ogunniyi A, Barbay M, Roussel M, Lee BC, Srikanth VK, Moran C, Kandiah N, Chander RJ, Sabayan B, Jukema JW, Melkas S, Erkinjuntti T, Brodaty H, Bordet R, Bombois S, Henon H, Lipnicki DM, Kochan NA, Sachdev PS, Stroke and Cognition C (2019) Profile of and risk factors for poststroke cognitive impairment in diverse ethnoregional groups. Neurology 93:e2257–e2271
Article PubMed PubMed Central Google Scholar
Kirshner H, Schrag M (2021) Management of intracerebral hemorrhage: update and future therapies. Curr Neurol Neurosci Rep 21:57
Hemphill JC 3rd, Greenberg SM, Anderson CS, Becker K, Bendok BR, Cushman M, Fung GL, Goldstein JN, Macdonald RL, Mitchell PH, Scott PA, Selim MH, Woo D, American Heart Association Stroke C, Council on C, Stroke N and Council on Clinical C (2015) Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 46:2032–2060
Bunevicius A, Iervasi G, Bunevicius R (2015) Neuroprotective actions of thyroid hormones and low-T3 syndrome as a biomarker in acute cerebrovascular disorders. Expert Rev Neurother 15:315–326
Article CAS PubMed Google Scholar
Huang G-Q, Zeng Y-Y, Cheng Q-Q, Cheng H-R, Ruan Y-T, Yuan C-X, Chen Y-B, He W-L, Chen H-J, He J-C (2019) Low triiodothyronine syndrome is associated with hemorrhagic transformation in patients with acute ischaemic stroke. Aging 11:6385–6397
Article CAS PubMed PubMed Central Google Scholar
Gao R, Chen RZ, Xia Y, Liang JH, Wang L, Zhu HY, Zhu WuJ, Fan L, Li JY, Yang T, Xu W (2018) Low T3 syndrome as a predictor of poor prognosis in chronic lymphocytic leukemia. Int J Cancer 143:466–477
Article CAS PubMed Google Scholar
Gao R, Liang JH, Wang L, Zhu HY, Wu W, Wu JZ, Xia Y, Cao L, Fan L, Yang T, Li JY, Xu W (2017) Low T3 syndrome is a strong prognostic predictor in diffuse large B cell lymphoma. Br J Haematol 177:95–105
Article CAS PubMed Google Scholar
He W, Pang C, Chen L, Zeng Y, Gao L, Huang H, Zhang W, Wang X, Deng B (2022) Low T3 syndrome is associated with peripheral neuropathy in patients with type 2 diabetes mellitus. Muscle Nerve 66:723–729
Article CAS PubMed Google Scholar
Mitchell JE, Hellkamp AS, Mark DB, Anderson J, Johnson GW, Poole JE, Lee KL, Bardy GH (2013) Thyroid function in heart failure and impact on mortality. JACC Heart Fail 1:48–55
Article PubMed PubMed Central Google Scholar
Qiao S, Zhang SC, Zhang RR, Wang L, Wang ZH, Jiang J, Wang AH, Liu XW (2022) Thyroid function and low free triiodothyronine in chinese patients with autoimmune encephalitis. Front Immunol 13:821746
Article CAS PubMed PubMed Central Google Scholar
Adams HP Jr, Davis PH, Leira EC, Chang KC, Bendixen BH, Clarke WR, Woolson RF, Hansen MD (1999) Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology. https://doi.org/10.1212/WNL.53.1.126
Zhu W, Zhou J, Ma B, Fan C (2024) Predictors of early neurological deterioration in patients with intracerebral hemorrhage: a systematic review and meta-analysis. J Neurol 271:2980–2991
Pradilla G, Ratcliff JJ, Hall AJ, Saville BR, Allen JW, Paulon G, McGlothlin A, Lewis RJ, Fitzgerald M, Caveney AF, Li XT, Bain M, Gomes J, Jankowitz B, Zenonos G, Molyneaux BJ, Davies J, Siddiqui A, Chicoine MR, Keyrouz SG, Grossberg JA, Shah MV, Singh R, Bohnstedt BN, Frankel M, Wright DW, Barrow DL, investigators Et and Investigators ET (2024) Trial of early minimally invasive removal of intracerebral hemorrhage. N Engl J Med 390:1277–1289
Article CAS PubMed Google Scholar
Banks JL, Marotta CA (2007) Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke 38:1091–1096
Peter-Derex L, Philippeau F, Garnier P, Andre-Obadia N, Boulogne S, Catenoix H, Convers P, Mazzola L, Gouttard M, Esteban M, Fontaine J, Mechtouff L, Ong E, Cho TH, Nighoghossian N, Perreton N, Termoz A, Haesebaert J, Schott AM, Rabilloud M, Pivot C, Dhelens C, Filip A, Berthezene Y, Rheims S, Boutitie F, Derex L (2022) Safety and efficacy of prophylactic levetiracetam for prevention of epileptic seizures in the acute phase of intracerebral haemorrhage (PEACH): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Neurol 21:781–791
Article CAS PubMed Google Scholar
Luo S, Yang WS, Shen YQ, Chen P, Zhang SQ, Jia Z, Li Q, Zhao JT, Xie P (2022) The clinical value of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and D-dimer-to-fibrinogen ratio for predicting pneumonia and poor outcomes in patients with acute intracerebral hemorrhage. Front Immunol 13:1037255
Article CAS PubMed PubMed Central Google Scholar
Masson P, Kelly PJ, Craig JC, Lindley RI, Webster AC (2015) Risk of stroke in patients with ESRD. Clin J Am Soc Nephrol 10:1585–1592
Article PubMed PubMed Central Google Scholar
Chu H, Huang C, Dong J, Yang X, Xiang J, Dong Q, Tang Y (2019) Lactate dehydrogenase predicts early hematoma expansion and poor outcomes in intracerebral hemorrhage patients. Transl Stroke Res 10:620–629
Article CAS PubMed Google Scholar
De La Mata NL, Masson P, Al-Shahi Salman R, Kelly PJ, Webster AC (2019) Death from stroke in end-stage kidney disease. Stroke 50:487–490
Sato S, Iso H, Noda H, Kitamura A, Imano H, Kiyama M, Ohira T, Okada T, Yao M, Tanigawa T, Yamagishi K, Nakamura M, Naito Y, Shimamoto T (2006) Plasma fibrinogen concentrations and risk of stroke and its subtypes among Japanese men and women. Stroke 37:2488–2492
Article CAS PubMed Google Scholar
Sadana P, Coughlin L, Burke J, Woods R, Mdzinarishvili A (2015) Anti-edema action of thyroid hormone in MCAO model of ischemic brain stroke: possible association with AQP4 modulation. J Neurol Sci 354:37–45
Article CAS PubMed Google Scholar
Costa LES, Clementino-Neto J, Mendes CB, Franzon NH, Costa EO, Moura-Neto V, Ximenes-da-Silva A (2019) Evidence of aquaporin 4 regulation by thyroid hormone during mouse brain development and in cultured human glioblastoma multiforme cells. Front Neurosci 13:317
Article PubMed PubMed Central Google Scholar
Chen S, Li L, Peng C, Bian C, Ocak PE, Zhang JH, Yang Y, Zhou D, Chen G, Luo Y (2022) Targeting oxidative stress and inflammatory response for blood-brain barrier protection in intracerebral hemorrhage. Antioxid Redox Signal 37:115–134
Article CAS PubMed Google Scholar
Wang X, Lo EH (2003) Triggers and mediators of hemorrhagic transformation in cerebral ischemia. Mol Neurobiol 28:229–244
Article CAS PubMed Google Scholar
Barakat-Walter I, Kraftsik R (2018) Stimulating effect of thyroid hormones in peripheral nerve regeneration: research history and future direction toward clinical therapy. Neural Regen Res 13:599–608
Article CAS PubMed PubMed Central Google Scholar
Courtin F, Zrouri H, Lamirand A, Li WW, Mercier G, Schumacher M, Goascogne CL, Pierre M (2005) Thyroid hormone deiodina
Comments (0)